SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Free and discounted weekend app on PlayStore – August 28th Aug 21, 2021
- Green pass Italy, Vaia: “Yes to an extension even beyond a year” Aug 26, 2021
- iPhone and iPad: how and what is the use of deleting the cache of Google Chrome May 26, 2022
- Mohamed VI expresses his intention to open a “new stage” with Spain Aug 20, 2021
- The kissing booth 3, ending explained by Joey King: he talked about its ambiguity Aug 13, 2021
- Here’s what that might look like the next Galaxy Note 20 May 22, 2020
- Atento Virtual Hub: remote control center for CX agents | News | Communications May 31, 2021